FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/094107 [Registered on: 02/09/2025] Trial Registered Prospectively
Last Modified On: 01/09/2025
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Other 
Public Title of Study   Predicting Recovery in Older Adults Undergoing Cancer Surgery: Insights from a New Scoring Tool (G8) 
Scientific Title of Study   Outcome analysis of geriatric patients undergoing major abdominal cancer surgeries using G8 scoring: a prospective observational study in a tertiary cancer centre in eastern India 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DEBARTHA BANDYOPADHYAY 
Designation  SPECIALIST GRADE2 
Affiliation  Chittaranjan National Cancer Institute 
Address  Chittaranjan National Cancer Institute, 2nd campus- Street no. 299, Plot no. DJ- 01, Premises no. 02-0321, Action area 1D, New Town, Kolkata- 700160

North Twentyfour Parganas
WEST BENGAL
700160
India 
Phone  9477019266  
Fax    
Email  bdebartha@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  DEBARTHA BANDYOPADHYAY 
Designation  SPECIALIST GRADE2 
Affiliation  Chittaranjan National Cancer Institute 
Address  Chittaranjan National Cancer Institute, 2nd campus- Street no. 299, Plot no. DJ- 01, Premises no. 02-0321, Action area 1D, New Town, Kolkata- 700160


WEST BENGAL
700160
India 
Phone  9477019266  
Fax    
Email  bdebartha@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  DEBARTHA BANDYOPADHYAY 
Designation  SPECIALIST GRADE2 
Affiliation  Chittaranjan National Cancer Institute 
Address  Chittaranjan National Cancer Institute, 2nd campus- Street no. 299, Plot no. DJ- 01, Premises no. 02-0321, Action area 1D, New Town, Kolkata- 700160


WEST BENGAL
700160
India 
Phone  9477019266  
Fax    
Email  bdebartha@yahoo.com  
 
Source of Monetary or Material Support  
Monetory support is not required exclusively for the study as it is observational, material support is from the institute 
 
Primary Sponsor  
Name  CHITTARANJAN NATIONAL CANCER INSTITUTE 
Address  NEW TOWN , ACTION AREA 1, RAJARHAT, KOKKATA-700160 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Debartha Bandyopadhyay  Chittaranjan National Cancer institute  2nd campus, Street No.-299, Plot No. DJ-01, Premises no.02-0321, Action Area 1D, New Town, Kolkata- 700160
Kolkata
WEST BENGAL 
9477019266

bdebartha@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE, Chittanranjan National Cancer Institute  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C15-C26||Malignant neoplasms of digestive organs, (2) ICD-10 Condition: C64-C68||Malignant neoplasms of urinary tract, (3) ICD-10 Condition: C51-C58||Malignant neoplasms of female genital organs,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  70.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  (i)age 70 years or older
(ii)referred for medical preoperative assessment for pre anaesthesia clearance
(iii)undergoing a single elective major abdominal oncosurgery. 
 
ExclusionCriteria 
Details  (i) Patients with metastatic disease,
(ii) emergency operations,
(iii) an expected life expectancy of less than 6 months,
(iv) initially planned for surgery but treated non-operatively. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To analyze the correlations of G8 scoring with post-operative complications. (according to Clavien-Dindo classification)  Time point will be till discharge from the hospital 
 
Secondary Outcome  
Outcome  TimePoints 
To analyze the association of G8 test with postoperative length of hospital stay, 30 day readmission and occurrence of post-operative delirium.   30 days 
 
Target Sample Size   Total Sample Size="85"
Sample Size from India="85" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The study analyses the association between G8 geriatric scoring with post operative complications. Study participants will be recruited at pre-anesthesia check up clinic being aged 70 years and above, scheduled to undergo major abdominal cancer surgeries. Patients will be classified according to G8 scoring into low, intermediate and high score group. Patients’  ASA  grading, functional status of the patient, tumor type and staging will be assessed. Baseline characteristics of three groups will be compared according to age, gender, type of intervention and cancer grading. Post operative outcomes as occurrence of major and minor complications, length of hospital stay, 30 day readmission and occurrence of post operative delirium will be compared among the groups. As primary outcome, post operative complications are defined and determined using Clavien- Dindo classification. The aim of this study will be to clarify whether G8 scoring, a geriatric screening tool, has independent prognostic value for elderly cancer patients undergoing major abdominal onco surgeries and what is the optimum cut-off  value for predicting complications.  
Close